Jérémie Calais - Concepedia

Author

Jérémie Calais

University of California, Los Angeles ORCID

Also Known As

Calais, Jeremie, Calais, Jérémie, J Calais, J. Calais, Jeremie Calais, Jeremie Calais*, Jérémie Calais

378

Publications

10.1K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles University of Duisburg-Essen Klinikum rechts der Isar Deutschen Konsortium für Translationale Krebsforschung University of California, San Francisco

About

Jérémie Calais is an author at University of California, Los Angeles specializing in oncology, medicine, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	33	1.7K
2	Health Sciences	17	21	1.3K
3	Engineering	12	12	484
4	Cell Biology	2	2	55
5	Diagnostic Sciences	2	2	68

Jérémie Calais

112

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer Wolfgang P. Fendler, Jérémie Calais, Matthias Eiber, JAMA Oncology	2019	749
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT Matthias Eiber, Ken Herrmann, Jérémie Calais, Journal of Nuclear Medicine	2017	574
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial Jérémie Calais, Francesco Ceci, Matthias Eiber, The Lancet Oncology Positron Emission TomographyUrologySurgical OncologyComparative Imaging TrialMedical Imaging	2019	452
Diagnostic Accuracy of <sup>68</sup>Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection Thomas A. Hope, Matthias Eiber, Wesley R. Armstrong, JAMA Oncology	2021	322
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0 Wolfgang P. Fendler, Matthias Eiber, Mohsen Beheshti, European Journal of Nuclear Medicine and Molecular Imaging	2023	319
<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning Jérémie Calais, Johannes Czernin, Minsong Cao, Journal of Nuclear Medicine	2017	260
Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Clinical Cancer Research	2019	256
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study Andrei Gafita, Jérémie Calais, Tristan Grogan, The Lancet Oncology	2021	228
Radiation Dosimetry and Biodistribution of <sup>68</sup>Ga-FAPI-46 PET Imaging in Cancer Patients Catherine Meyer, Magnus Dahlbom, Thomas Lindner, Journal of Nuclear Medicine	2019	223
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT) Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber, European Journal of Nuclear Medicine and Molecular Imaging	2023	215

Page 1